Key result
KardiaMobile 6-lead ECG guides clinical decision-making in ~87% of outpatient cardiology encounters.
Why the study?
The feasibility of using a portable KardiaMobile 6-lead ECG device as an alternative to the standard 12-lead ECG to guide clinical management in outpatient cardiology practice needed evaluation.
Does a portable 6-lead ECG device provide sufficient information to guide clinical decision-making in routine outpatient cardiology encounters?
Observational (n=101)
No
Does a portable 6-lead ECG device provide sufficient information to guide clinical decision-making in routine outpatient cardiology encounters?
A portable 6-lead ECG device provided sufficient clinical information to guide management in 87% of routine outpatient cardiology encounters, supporting its utility as a preliminary assessment tool.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for 6-lead ECG in outpatients; prospective trials needed before clinical adoption.
The objective of this pilot study was to evaluate the feasibility of using the KardiaMobile 6‑lead ECG device as an alternative to the standard 12‑lead ECG in an outpatient cardiology practice to guide clinical management. In the majority of encounters (87%, N = 101), six participating cardiologists reported that the 6‑lead ECG provided sufficient information to guide clinical decision-making in consultations and follow-up appointments. Our results support using the 6‑lead device as a preliminary assessment tool for routine outpatient encounters. Considering the device's affordability and portability, there are real-world opportunities to implement this technology in other medical specialties and underserved communities.
No takes yet. Share an insight, caveat, or question.
Neumark et al. (2026) conducted an observational in Outpatient cardiology consultations and follow-up appointments (n=101). KardiaMobile 6-lead ECG device vs. Standard 12-lead ECG was evaluated on Provision of sufficient information to guide clinical decision-making. The KardiaMobile 6-lead ECG device provided sufficient information to guide clinical decision-making in 87% (N = 101) of outpatient cardiology encounters.
Synapse has enriched 10 related papers. Consider them for comparative context: